2016
DOI: 10.1111/pan.12909
|View full text |Cite
|
Sign up to set email alerts
|

Anesthetic management of 877 pediatric patients undergoing muscle biopsy for neuromuscular disorders: a 20‐year review

Abstract: In this retrospective study, no patient exhibited signs or symptoms of hyperkalemia or MH probably because the incidence is very low and becomes even less likely due to the selection of the various anesthetic agents and strategies administered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 106 publications
(28 citation statements)
references
References 75 publications
0
24
0
2
Order By: Relevance
“…Given the complexity of perioperative management in patients with NMDs and the potential for poor outcomes in patients that are not managed judiciously, there exists a need for establishing multidisciplinary guidance for standardizing the care these patients receive. A large retrospective study of patients with NMDs undergoing muscle biopsies revealed no serious complications, and its authors concluded that “increased awareness of anesthesia-related concerns in an NMD patient directs management along specific safe pathways” [ 25 ]. While increased awareness is evident from multiple existing reviews of perioperative concerns for patients with NMDs [ 5 , 17 , 18 , 19 , 20 , 24 , 26 , 27 , 28 , 29 ], most have been directed toward anesthesia providers and very few define in precise and actionable ways the “specific safe pathways” that should be followed throughout the perioperative continuum of care.…”
Section: Multidisciplinary Considerations For Perioperative Care Fmentioning
confidence: 99%
“…Given the complexity of perioperative management in patients with NMDs and the potential for poor outcomes in patients that are not managed judiciously, there exists a need for establishing multidisciplinary guidance for standardizing the care these patients receive. A large retrospective study of patients with NMDs undergoing muscle biopsies revealed no serious complications, and its authors concluded that “increased awareness of anesthesia-related concerns in an NMD patient directs management along specific safe pathways” [ 25 ]. While increased awareness is evident from multiple existing reviews of perioperative concerns for patients with NMDs [ 5 , 17 , 18 , 19 , 20 , 24 , 26 , 27 , 28 , 29 ], most have been directed toward anesthesia providers and very few define in precise and actionable ways the “specific safe pathways” that should be followed throughout the perioperative continuum of care.…”
Section: Multidisciplinary Considerations For Perioperative Care Fmentioning
confidence: 99%
“…Specific proteins within the dystrophin‐glycoprotein complex, responsible for muscle membrane stability , are abnormal in the dystrophies and certain of the myopathies. Children with these rare diseases appear to be at increased risk of developing AIR on exposure to halogenated agents yet the reaction is idiosyncratic, not happening in every patient, and not with every exposure, as demonstrated in two case series in which no such reactions were recorded despite the use, in certain cases, of suxamethonium and/or halogenated agents. It would appear that more than just the presence of a disorder and such an agent is required.…”
Section: Diagnosismentioning
confidence: 99%
“…8 Os pacientes suscetíveis à hipertermia maligna também devem evitar uso de bloqueadores de canal de cálcio. Não há relato de associação entre episódios de hipertermia maligna e uso de relaxantes musculares adespolarizantes [9][10][11] , porém devem ser evitados em todos os pacientes portadores de doenças neuromusculares, visto que a maioria desses pacientes apresenta mais sensibilidade a esses agentes, com instalação mais rápida do bloqueio e mais tempo de ação. 10 Se o uso for absolutamente necessário, devem-se utilizar 10 a 20% da dose recomendada e monitorar o grau de bloqueio neuromuscular.…”
Section: Poliomieliteunclassified